The mission of the Human Immunology and Immunotherapy Initiative is to establish an all-inclusive premier facility on the CU Anschutz medical campus focused on the comprehensive development and delivery of human immune system-targeted therapies.
To recruit new faculty who will complement the existing strengths and expertise on this campus as well as those who have outstanding expertise in human immunology and the development and delivery of immunotherapeutics. Faculty searches are focused on the areas of basic human immunology, autoimmunity, and cancer.
Autoimmunity – Michael Holers, MD, Head, Division of Rheumatology
Basic Human Immunology – Rosemary Rochford, PhD, Professor, Department of Immunology & Microbiology
Cancer – Wells Messersmith, MD, Professor and Co-Division Head, Division of Medical Oncology
To establish a human immune monitoring core and mass cytometry facility to facilitate clinical and translational studies that aim to dissect mechanisms of immunopathogenesis and identify novel disease-specific biomarkers with diagnostic and therapeutic applications. The HIMSR team offers expert consultation on immunology-related projects and the discussion of appropriate research endpoints and assays.
Jill Slansky, PhD, Director Human Immune Monitoring Shared Resource (HIMSR), Professor Department of Immunology & Microbiology
Kim Jordan, PhD, Assistant Director Human Immune Monitoring Shared Resource (HIMSR), Department of Immunology & Microbiology
Elena Hsieh, MD, Experimental Design Consultant Human Immune Monitoring Shared Resource (HIMSR), Assistant Professor Department of Immunology & Microbiology, Department of Pediatrics
To provide a nexus for multiple aspects of translational immunology research. The TRNPM enables and promotes collaboration among investigators along the continuum of basic-translational-clinical research by establishing mechanisms that facilitate availability of human tissue for research and by generating and maintaining humanized mouse models, hu-mice, for the development and preclinical testing of novel therapeutics.
Roberta Pelanda, PhD, Professor, Department of Immunology & Microbiology
Julie Lang, PhD, Senior Research Associate, Department of Immunology & Microbiology
To collaborate with GMP facilities toward the production of clinical grade biological reagents and cell-based immunotherapeutic products.
Terry Fry, MD, co-Director, HI3
To develop and establish training programs across the training continuum at the pre-doctoral, post-doctoral, and junior faculty level to train the next generation of scientists who will become leaders in the area of immunotherapy. Coming soon!
To successfully guide HI3 investigators through the complicated web of established CU clinical research support services. Coming soon!